Literature DB >> 24352468

Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.

Roger D Everett1, Chris Boutell, Kathleen Pheasant, Delphine Cuchet-Lourenço, Anne Orr.   

Abstract

UNLABELLED: Herpes simplex virus type 1 immediate-early protein ICP0 is an E3 ubiquitin ligase of the RING finger class that degrades several cellular proteins during infection. This activity is essential for its functions in stimulating efficient lytic infection and productive reactivation from latency. ICP0 targets a number of proteins that are modified by the small ubiquitin-like SUMO family of proteins, and it includes a number of short sequences that are related to SUMO interaction motifs (SIMs). Therefore, ICP0 has characteristics that are related to those of cellular SUMO-targeted ubiquitin ligase enzymes. Here, we analyze the impact of mutation of a number of SIM-like sequences (SLSs) within ICP0 on HSV-1 replication and gene expression and their requirement for ICP0-mediated degradation of both sumoylated and unmodified promyelocytic leukemia (PML) and other sumoylated cellular proteins. One SLS in the central portion of the ICP0 sequence (SLS4) was found to be absolutely required for targeting cellular sumoylated species in general and sumoylated forms of PML other than those of PML isoform I. Mutation of a group of SLSs in the C-terminal quarter of ICP0 also reduced ICP0-mediated degradation of sumoylated PML in a cooperative manner. Although mutation of individual SLSs caused only modest decreases in viral replication, combined mutation of SLS4 with SLS sequences in the C-terminal quarter of the protein reduced plaque formation efficiency by up to two orders of magnitude. These results provide further evidence that the biological activities of ICP0 are connected with host cell sumoylation events. IMPORTANCE: Herpes simplex virus type 1 protein ICP0 plays important roles in regulating the initial stages of lytic infection and productive reactivation from latency. ICP0 mediates its effects through inducing the degradation of cellular proteins that have repressive effects on viral gene expression. An increasing number of cellular proteins are known to be sensitive to ICP0-mediated degradation; therefore, it is important to understand how ICP0 selects its substrates for degradation. This study identifies sequence motifs within ICP0 that are involved in targeting cellular proteins that are modified by the SUMO family of ubiquitin-like proteins and describes how mutation of combinations of these motifs causes a 100-fold defect in viral infectivity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24352468      PMCID: PMC3958091          DOI: 10.1128/JVI.03417-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.

Authors:  Delphine Cuchet-Lourenço; Emilia Vanni; Mandy Glass; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

2.  The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0.

Authors:  G G Maul; R D Everett
Journal:  J Gen Virol       Date:  1994-06       Impact factor: 3.891

3.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  Infection of a human hepatoma cell line by hepatitis B virus.

Authors:  Philippe Gripon; Sylvie Rumin; Stephan Urban; Jacques Le Seyec; Denise Glaise; Isabelle Cannie; Claire Guyomard; Josette Lucas; Christian Trepo; Christiane Guguen-Guillouzo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

5.  Influenza A virus interacts extensively with the cellular SUMOylation system during infection.

Authors:  Sangita Pal; Andres Santos; Juan M Rosas; Joshua Ortiz-Guzman; Germán Rosas-Acosta
Journal:  Virus Res       Date:  2011-03-03       Impact factor: 3.303

6.  The mechanisms of PML-nuclear body formation.

Authors:  Tian Huai Shen; Hui-Kuan Lin; Pier Paolo Scaglioni; Thomas M Yung; Pier Paolo Pandolfi
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

7.  HSV-1 IE protein Vmw110 causes redistribution of PML.

Authors:  R D Everett; G G Maul
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

8.  Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.

Authors:  Li Wang; Stefan L Oliver; Marvin Sommer; Jaya Rajamani; Mike Reichelt; Ann M Arvin
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

Review 9.  PML and PML nuclear bodies: implications in antiviral defence.

Authors:  Roger D Everett; Mounira K Chelbi-Alix
Journal:  Biochimie       Date:  2007-01-27       Impact factor: 4.079

10.  SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes.

Authors:  Delphine Cuchet-Lourenço; Chris Boutell; Vera Lukashchuk; Kyle Grant; Amanda Sykes; Jill Murray; Anne Orr; Roger D Everett
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

View more
  15 in total

1.  Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.

Authors:  Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

Review 2.  Infected cell protein 0 functional domains and their coordination in herpes simplex virus replication.

Authors:  Haidong Gu
Journal:  World J Virol       Date:  2016-02-12

3.  MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human Cytomegalovirus.

Authors:  Elizabeth Sloan; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

4.  A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1.

Authors:  Yi Zheng; Subodh Kumar Samrat; Haidong Gu
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

5.  A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro.

Authors:  Chris Boutell; David J Davido
Journal:  Methods       Date:  2015-04-08       Impact factor: 3.608

6.  Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.

Authors:  Thamir Alandijany; Ashley P E Roberts; Kristen L Conn; Colin Loney; Steven McFarlane; Anne Orr; Chris Boutell
Journal:  PLoS Pathog       Date:  2018-01-08       Impact factor: 6.823

7.  Orthoreovirus outer-fiber proteins are substrates for SUMO-conjugating enzyme Ubc9.

Authors:  Fei Yu; Hao Wang; Longlong Wang; Liqun Lu
Journal:  Oncotarget       Date:  2016-11-29

8.  Analysis of the SUMO2 Proteome during HSV-1 Infection.

Authors:  Elizabeth Sloan; Michael H Tatham; Marine Groslambert; Mandy Glass; Anne Orr; Ronald T Hay; Roger D Everett
Journal:  PLoS Pathog       Date:  2015-07-22       Impact factor: 7.464

9.  Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.

Authors:  Kristen L Conn; Peter Wasson; Steven McFarlane; Lily Tong; James R Brown; Kyle G Grant; Patricia Domingues; Chris Boutell
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 10.  Immune Response to Herpes Simplex Virus Infection and Vaccine Development.

Authors:  Anthony C Ike; Chisom J Onu; Chukwuebuka M Ononugbo; Eleazar E Reward; Sophia O Muo
Journal:  Vaccines (Basel)       Date:  2020-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.